, 1962) and potential therapeutic effects in human beings. The early clinical trials employed mostly LSD while the majority of the latest hallucinogen studies used psilocybin due to its simplicity of use a result of the shorter motion and less controversial history (Nichols et al An evaluation with a person https://socialfactories.com/story3070361/top-latest-five-lsd-microdosing-benefits-and-risks-urban-news